Intracellular Bacterial Pathogen Therapeutic Target Product Profile Guidelines

Abstract

The Transformational Medical Technologies Initiative (TMTI) program was given broad guidance through the current Initial Capabilities Documents (ICDs) to develop broad-spectrum medical therapeutics to mitigate the negative operational impact of a biological attack. The therapeutic must be safe and effective, easy to use, and cause minimal side-effects. This Target Product Profile (TPP) guideline describes drug candidates to be used as therapeutics targeted against intracellular bacterial pathogens. The drug candidates will be used to treat patients who have been exposed to the pathogen, are symptomatic, and who have the potential to be hospitalized for medical treatment.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Feb 24, 2009
Accession Number
ADA514790

Entities

Organizations

  • Office Of The Under Secretary Of Defense

Tags

DTIC Thesaurus Topics

  • Anti-Bacterial Agents
  • Bacteria
  • Bacterial Diseases
  • Bacterial Infections
  • Biological Warfare
  • Biological Warfare Agents
  • Countermeasures
  • Department Of Defense
  • Diseases And Disorders
  • Genetically Modified Organisms
  • Health Services
  • Pathogenic Bacteria
  • Program Management
  • Public Health
  • Side Effects
  • Standards
  • Therapy

Fields of Study

  • Medicine

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Software Engineering